CVE:RVV - Revive Therapeutics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$0.16 -0.02 (-8.82 %) (As of 04/23/2019 12:45 PM ET)Previous CloseC$0.17Today's RangeC$0.16 - C$0.1752-Week RangeC$0.09 - C$0.30Volume57,885 shsAverage Volume117,540 shsMarket CapitalizationC$11.22 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada. Receive RVV News and Ratings via Email Sign-up to receive the latest news and ratings for RVV and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:RVV Previous Symbol CUSIPN/A CIKN/A Webwww.revivethera.com Phone+1-905-6055535Debt Debt-to-Equity RatioN/A Current Ratio1.92 Quick Ratio1.76Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.01 per share Price / Cash Flow21.25 Book ValueC$0.01 per share Price / Book31.00Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares72,411,000Market CapC$11.22 million Next Earnings Date5/29/2019 (Estimated) OptionableNot Optionable Revive Therapeutics (CVE:RVV) Frequently Asked Questions What is Revive Therapeutics' stock symbol? Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV." How were Revive Therapeutics' earnings last quarter? Revive Therapeutics Ltd (CVE:RVV) posted its quarterly earnings data on Thursday, February, 28th. The company reported ($0.01) EPS for the quarter. View Revive Therapeutics' Earnings History. When is Revive Therapeutics' next earnings date? Revive Therapeutics is scheduled to release their next quarterly earnings announcement on Wednesday, May 29th 2019. View Earnings Estimates for Revive Therapeutics. Has Revive Therapeutics been receiving favorable news coverage? News articles about RVV stock have trended positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Revive Therapeutics earned a media sentiment score of 2.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. Who are some of Revive Therapeutics' key competitors? Some companies that are related to Revive Therapeutics include Prana Biotechnology (PBT), Rhinomed (RNO), Rexahn Pharmaceuticals (RNN), Quest PharmaTech (QPT), Altimmune (ALT), Rexahn Pharmaceuticals (RNN), Nuvo Pharmaceuticals (NRI), Living Cell Technologies (LCT), Microbix Biosystems (MBX), Anatara Lifesciences (ANR), Oragenics (OGEN), Skinbiotherapeutics (SBTX), Galena Biopharma (SLS), Faron Pharmaceuticals Oy (FARN) and Scancell (SCLP). What other stocks do shareholders of Revive Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Revive Therapeutics investors own include Okta (OKTA), MOL Global (MOLGY), Aurora Cannabis (ACB), Canopy Growth (WEED), ICC Labs (ICC), iAnthus Capital (IAN), Hempco Food and Fiber (HEMP), Supreme Cannabis (FIRE), Emblem (EMC) and Canabo Medical (CMM). Who are Revive Therapeutics' key executives? Revive Therapeutics' management team includes the folowing people: Mr. Craig Leon, Chairman & CEO (Age 51)Mr. Fabio Chianelli, Pres & Director (Age 41)Mr. Carmelo Marrelli C.A., C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer (Age 48) How do I buy shares of Revive Therapeutics? Shares of RVV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Revive Therapeutics' stock price today? One share of RVV stock can currently be purchased for approximately C$0.16. How big of a company is Revive Therapeutics? Revive Therapeutics has a market capitalization of C$11.22 million. What is Revive Therapeutics' official website? The official website for Revive Therapeutics is http://www.revivethera.com/. How can I contact Revive Therapeutics? Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535. MarketBeat Community Rating for Revive Therapeutics (CVE RVV)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 44 (Vote Outperform)Underperform Votes: 47 (Vote Underperform)Total Votes: 91MarketBeat's community ratings are surveys of what our community members think about Revive Therapeutics and other stocks. Vote "Outperform" if you believe RVV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RVV will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/23/2019 by MarketBeat.com StaffFeatured Article: What is a Candlestick Chart?